Cite
MLA Citation
Vincent Leroy et al.. “Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+).” Hepatology, vol. 63, no. 5, n.d., pp. 1430–1441. http://access.bl.uk/ark:/81055/vdc_100031980766.0x00002e